Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
OSIVAX - CLINICAL PROOF OF CONCEPT OF OVX836, A SINGLE-SHOT BROADLY PROTECTIVE INFLUENZA A VACCINE FOR IMMEDIATE PROTECTION AGAINST EMERGING PANDEMIC STRAINS
Task order obligations
Estimated months remaining until end of performance.
Period of performance
29% of period elapsed
Awardee
OSOSIVAX
UEI: M4YDKJJRJYC7
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|